Literature DB >> 12829979

Kinetics of the immune response during HBV and HCV infection.

Antonio Bertoletti1, Carlo Ferrari.   

Abstract

The innate immune system has a role not only in protecting the host during the initial period of virus infection, but also in shaping the nature of the adaptive immune response. In this review, we follow the kinetics of the virologic and immunologic events occurring from the time of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. We primarily discuss how the early events after infection might influence the development of the adaptive immune response in these 2 important viral infections and how new strategies for more efficient preventive and therapeutic vaccines can be derived from this knowledge.

Entities:  

Mesh:

Year:  2003        PMID: 12829979     DOI: 10.1053/jhep.2003.50310

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  72 in total

1.  Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.

Authors:  F Torre; S Rossol; N Pelli; M Basso; A Delfino; A Picciotto
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

2.  Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts.

Authors:  Masatoshi Ishigami; Hideya Kamei; Taro Nakamura; Yoshiaki Katano; Hisami Ando; Tetsuya Kiuchi; Hidemi Goto
Journal:  J Gastroenterol       Date:  2010-09-11       Impact factor: 7.527

3.  Occult hepatitis B in blood donors: a description of two cases.

Authors:  Ciro Capezzuto; Eva Franchi; Simona Urbani; Luisa Romanò; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

4.  Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B.

Authors:  Rosa Zampino; Emanuele Durante Mangoni; Aldo Marrone; Riccardo Utili; Giuseppe Ruggiero; Luigi Elio Adinolfi
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

5.  Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.

Authors:  M Shi; S Qian; W-W Chen; H Zhang; B Zhang; Z-R Tang; Z Zhang; F-S Wang
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

6.  Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells.

Authors:  Jong Ha Jung; Ji Hoon Park; Min Hyeok Jee; Sun Ju Keum; Min-Sun Cho; Seung Kew Yoon; Sung Key Jang
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 7.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 8.  Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection.

Authors:  Meenakshi Sachdeva; Yogesh K Chawla; Sunil K Arora
Journal:  World J Hepatol       Date:  2015-09-08

9.  Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.

Authors:  Sílvia Vilarinho; Kouetsu Ogasawara; Stephen Nishimura; Lewis L Lanier; Jody L Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

10.  B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function.

Authors:  Gang Cai; Xiaomeng Nie; Lei Li; Liang Hu; Beiying Wu; Jiafei Lin; Cen Jiang; Huaizhou Wang; Xuefeng Wang; Qian Shen
Journal:  J Gastroenterol       Date:  2013-03-27       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.